Pharmaceutisch weekblad. Scientific edition最新文献

筛选
英文 中文
Delivery of hormones: some new concepts. 激素输送:一些新概念。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962547
W A Hermens
{"title":"Delivery of hormones: some new concepts.","authors":"W A Hermens","doi":"10.1007/BF01962547","DOIUrl":"https://doi.org/10.1007/BF01962547","url":null,"abstract":"<p><p>Some new concepts in the delivery of hormones are described. Transmucosal or transdermal penetration of hormones can be facilitated, often by the use of absorption enhancers. Studies of nasal insulin delivery are described. Recently developed iontophoretic delivery devices can be useful for pulsatile transdermal administration of peptide hormones. A self-regulating delivery system releasing insulin in response to glucose levels is described. A vaginal ring releasing ethinylestradiol and 3-ketodesogestrel is a new concept in long-acting contraception. A nasal estradiol formulation, containing the absorption enhancer dimethyl-beta-cyclodextrin, is an interesting alternative to oral and transdermal delivery of female sex hormones.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"253-7"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962547","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparative study on protective gloves for handling cytotoxic medicines: a model study with carmustine. 细胞毒性药物防护手套的比较研究:卡莫司汀模型研究。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962535
H Dinter-Heidorn, G Carstens
{"title":"Comparative study on protective gloves for handling cytotoxic medicines: a model study with carmustine.","authors":"H Dinter-Heidorn,&nbsp;G Carstens","doi":"10.1007/BF01962535","DOIUrl":"https://doi.org/10.1007/BF01962535","url":null,"abstract":"<p><p>The quality of protective gloves was studied. Protective gloves are part of the personal safety equipment for staff handling cytotoxic drugs. A study using raster electron microscopic photography, measurement of thickness by micrometer screw and permeability of carmustine by high pressure liquid chromatographic assay was carried out. The results show differences between different types of gloves.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4","pages":"180-4"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962535","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Drugs in the pipeline. Proceedings of the scientific meeting of the Dutch Association of Hospital Pharmacists. Valkenburg, 13-14 September 1991. 药物正在研发中。荷兰医院药剂师协会科学会议记录。1991年9月13日至14日,瓦尔肯堡。
{"title":"Drugs in the pipeline. Proceedings of the scientific meeting of the Dutch Association of Hospital Pharmacists. Valkenburg, 13-14 September 1991.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"205-86"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New cytotoxic drugs and targets in oncology. 新的肿瘤细胞毒药物和靶点。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962548
J H Beijnen
{"title":"New cytotoxic drugs and targets in oncology.","authors":"J H Beijnen","doi":"10.1007/BF01962548","DOIUrl":"https://doi.org/10.1007/BF01962548","url":null,"abstract":"<p><p>New agents in the preclinical and early clinical pipeline (phases I and II) are described and some of the problems associated with their development are reviewed. The article focuses on tubulin poisons such as taxol, topoisomerase inhibitors, such as topotecan, and drugs such as bryostatin 1 and miltefosin, which interfere with specific signal transduction pathways involved in malignant cell growth.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"258-67"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962548","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clearance of indomethacin occurs predominantly by renal glucuronidation. 吲哚美辛的清除主要通过肾糖醛酸化发生。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962537
F Moolenaar, S Crancrinus, J Visser, D De Zeeuw, D K Meijer
{"title":"Clearance of indomethacin occurs predominantly by renal glucuronidation.","authors":"F Moolenaar,&nbsp;S Crancrinus,&nbsp;J Visser,&nbsp;D De Zeeuw,&nbsp;D K Meijer","doi":"10.1007/BF01962537","DOIUrl":"https://doi.org/10.1007/BF01962537","url":null,"abstract":"<p><p>In this report we describe the conditions of collection, storage and handling of urine samples, collected after oral dosing with indomethacin in man, in order to maintain the integrity of the labile glucuronide formed. We found that the body clearance occurs predominantly by renal metabolism, due to glucuronidation in the human kidney. These glucuronides may be converted to isomeric glucuronides and/or the parent compound indomethacin during the residence time in the bladder.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4","pages":"191-5"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962537","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Future directions in antimicrobial chemotherapy. 抗菌化疗的未来方向。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962545
R Janknegt
{"title":"Future directions in antimicrobial chemotherapy.","authors":"R Janknegt","doi":"10.1007/BF01962545","DOIUrl":"https://doi.org/10.1007/BF01962545","url":null,"abstract":"<p><p>New developments in the treatment of bacterial infections are discussed. The most important developments include oral broad-spectrum cephalosporin derivatives and extended-spectrum injectable cephalosporins with improved activity against Gram-positive bacteria. Meropenem is a new carbapenem agent with markedly improved activity against Gram-negative bacteria. Many fluoroquinolones are in various phases of development. The most interesting new compound is sparfloxacin. Azithromycin is a new macrolide which, because of its very long half-life, attains very high levels in most tissues. Potential uses of the newer agents are discussed.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"229-44"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962545","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New developments in the pharmacotherapy of inflammatory bowel disease. 炎症性肠病药物治疗的新进展。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962550
J W Harting
{"title":"New developments in the pharmacotherapy of inflammatory bowel disease.","authors":"J W Harting","doi":"10.1007/BF01962550","DOIUrl":"https://doi.org/10.1007/BF01962550","url":null,"abstract":"<p><p>In this article the clinical features and aetiology of inflammatory bowel diseases are described and current pharmacotherapeutic possibilities are explored. Also reviewed are recent developments and future prospects for the pharmacotherapy of inflammatory bowel diseases, including aminosalicylates, corticosteroids, immunosuppressants, lipoxygenase inhibitors, fish oil, sucralfate, bismuth compounds, free radical scavengers, (hydroxy)chloroquine, sodium cromoglycate and methotrexate.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"275-86"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962550","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12607928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Dealing with sadness, madness and hostility. New psychotropic drug remedies for the future. 处理悲伤、疯狂和敌意。未来新的精神药物疗法。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962542
A J Loonen
{"title":"Dealing with sadness, madness and hostility. New psychotropic drug remedies for the future.","authors":"A J Loonen","doi":"10.1007/BF01962542","DOIUrl":"https://doi.org/10.1007/BF01962542","url":null,"abstract":"<p><p>The objective of this article is to present an overview of new forms of psychotropic drug therapy that may be expected to play a role in psychiatric practice in the 1990s. In predicting these future developments, three lines of approach have been followed. Firstly, progress in elucidating basic neuronal mechanisms is described. The radioligand receptor binding technique has proved to be an especially powerful tool in the search for novel psychoactive compounds. Secondly, those mental health problems most likely to undergo intensive study are discussed. It is likely that special attention will be devoted to organic mental disorders related to aging (dementia) or chronic exposure to toxic substances. In addition, research will be aimed at explaining and reducing the occurrence of auto-aggressive and hetero-aggressive behaviour. Thirdly, the types of newly designed agents and treatment strategies currently under investigation are outlined. In particular, the development of pharmacological agents that interfere with serotonergic molecular mechanisms has opened the way to improving existing psychotropic drugs, to inventing drugs that achieve known clinical effects via different mechanisms of action, and even to discovering entirely new categories of psychotropic drugs.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"206-20"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962542","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Immunomodulators. Future prospects. 免疫调制剂。未来的前景。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-08-21 DOI: 10.1007/BF01962546
B C Takx-Köhlen
{"title":"Immunomodulators. Future prospects.","authors":"B C Takx-Köhlen","doi":"10.1007/BF01962546","DOIUrl":"https://doi.org/10.1007/BF01962546","url":null,"abstract":"<p><p>The future role of the immunomodulators in medical practice is yet to be defined. The key question is whether these new substances will bring remarkable progress in transplantation or in the treatment of such conditions as cancer, AIDS, and autoimmune diseases, or whether they will be of only minor adjunctive importance. As background to the discussion of immunomodulating agents, the immune system is explained, with emphasis on the roles of T and B lymphocytes, macrophages, phagocytes, human leukocyte antigen and the complement system. Special attention is given to the cytokines, particularly the lymphokines. The immunomodulators can be divided into three main groups: immunosuppressive agents, such as FK 506 and rapamycin; immunostimulating agents, of which BCG vaccine is most important; and the remaining immunomodulators, which include the biological response modifiers. The last group, which encompasses the colony-stimulating factors (GM-CSF, G-CSF, and M-CSF), the interleukins, the interferons, and the tumour necrosis factors, is described in detail. Innovative research and medical applications of these cytokines, including indications, contraindications, and adverse reactions, are discussed. The role of monoclonal antibodies against endotoxins is also described.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 4A","pages":"245-52"},"PeriodicalIF":0.0,"publicationDate":"1992-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962546","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12608053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Strategies for identifying and developing new anticonvulsant drugs. 新抗惊厥药物的鉴定和开发策略。
Pharmaceutisch weekblad. Scientific edition Pub Date : 1992-06-19 DOI: 10.1007/BF01962704
H J Kupferberg
{"title":"Strategies for identifying and developing new anticonvulsant drugs.","authors":"H J Kupferberg","doi":"10.1007/BF01962704","DOIUrl":"https://doi.org/10.1007/BF01962704","url":null,"abstract":"<p><p>The identification of new anticonvulsant drugs depends on the use of different animal models of epilepsy. The models should be mechanism-independent, able to screen a large number of compounds, at limited cost and technical expertise. Primary screening models include genetic or reflex models of epilepsy and electrically and chemically induced seizures. Once active compounds have been identified, more advanced mechanistic and seizure-specific models are needed to refine the choice of a lead compound. These can be either in vivo or in vitro models. Models known to interact with specific receptors or the production of the putative neurotransmitters of neural excitability or inhibition are valuable in assessing possible mechanisms of action. In vitro models have evolved as important tools in correlating changes in electrical phenomena and therapeutic spectrum. The use of the hippocampal slice and the cultured neuron permits classification of anticonvulsant activity based on cellular actions of the drug. Interactions by the experimental drugs with specific subcellular fractions of the central nervous system augment information on possible mechanisms of action. The final choice of compounds for development requires synthesizing and comparing all of the pharmacodynamic information with the pharmacokinetic and toxicologic data. In the final analysis, no single animal model of epilepsy known today can assure the development of better drugs for all treatment of the epilepsies.</p>","PeriodicalId":19804,"journal":{"name":"Pharmaceutisch weekblad. Scientific edition","volume":"14 3A","pages":"132-8"},"PeriodicalIF":0.0,"publicationDate":"1992-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF01962704","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12670716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信